Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Lemaitre Vascular (LMAT) Return on Equity (2016 - 2025)

Historic Return on Equity for Lemaitre Vascular (LMAT) over the last 15 years, with Q3 2025 value amounting to 0.14%.

  • Lemaitre Vascular's Return on Equity rose 200.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.14% for FY2024, which is 300.0% up from last year.
  • Lemaitre Vascular's Return on Equity amounted to 0.14% in Q3 2025, which was up 200.0% from 0.13% recorded in Q2 2025.
  • Lemaitre Vascular's 5-year Return on Equity high stood at 0.16% for Q2 2021, and its period low was 0.08% during Q1 2023.
  • In the last 5 years, Lemaitre Vascular's Return on Equity had a median value of 0.11% in 2024 and averaged 0.11%.
  • Its Return on Equity has fluctuated over the past 5 years, first skyrocketed by 500bps in 2021, then tumbled by -700bps in 2022.
  • Quarter analysis of 5 years shows Lemaitre Vascular's Return on Equity stood at 0.11% in 2021, then decreased by -28bps to 0.08% in 2022, then skyrocketed by 33bps to 0.1% in 2023, then grew by 27bps to 0.13% in 2024, then rose by 9bps to 0.14% in 2025.
  • Its Return on Equity was 0.14% in Q3 2025, compared to 0.13% in Q2 2025 and 0.13% in Q1 2025.